


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app29.us.archive.org';v.server_ms=213;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Pregnancy outcomes after assisted human reproduction. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712203141im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712203141im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712203141im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712203141im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712203141/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712203141im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712203141cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712203141js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712203141if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712203141/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712203141if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712203141/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712203141/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712203141/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712203141/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712203141/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712203141/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712203141/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712203141/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712203141/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712203141/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712203141/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712203141/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712203141/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712203141/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712203141/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712203141/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712203141/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712203141/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712203141/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712203141/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712203141/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712203141/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712203141/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712203141/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712203141/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010292</li>
            <li>2006 Mar (revised 2014 Jan)
            </li>            
                                </ul>
        <div>
                <h1>Pregnancy outcomes after assisted human reproduction.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712203141/https://www.guideline.gov/search?f_Guideline_Developer_String=Society%20of%20Obstetricians%20and%20Gynaecologists%20of%20Canada&amp;fLockTerm=Society%2Bof%2BObstetricians%2Band%2BGynaecologists%2Bof%2BCanada">Society of Obstetricians and Gynaecologists of Canada</a></li>
                        <li>   
                                <a id="581" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Society of Obstetricians and Gynaecologists of Canada, Okun N, Sierra S. Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can. 2014 Jan;36(1):64-83. [176 references] <a href="https://web.archive.org/web/20180712203141/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=24444289" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712203141im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table>                    <p><a href="/web/20180712203141/https://www.guideline.gov/Home/Disclaimer?id=47875&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fsogc.org%252fguidelines%252fpregnancy-outcomes-assisted-human-reproduction%252f">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712203141im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Allen VM, Wilson RD, Cheung A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC); Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC). Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006 Mar;28(3):220-50. [117 references]</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                            <h4>UMLS Concepts <a href="/web/20180712203141/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712203141/https://www.guideline.gov/search?f_ICD9CM_CUI=C0000768&amp;fLockTerm=Congenital+anomaly%2c+unspecified">Congenital anomaly, unspecified</a>
 (759.9), <a href="/web/20180712203141/https://www.guideline.gov/search?f_ICD9CM_CUI=C0021361&amp;fLockTerm=Infertility%2c+female%2c+of+unspecified+origin">Infertility, female, of unspecified origin</a>
 (628.9), <a href="/web/20180712203141/https://www.guideline.gov/search?f_ICD9CM_CUI=C0021364&amp;fLockTerm=Male+infertility%2c+unspecified">Male infertility, unspecified</a>
 (606.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0008625&amp;fLockTerm=Chromosome+Aberrations">Chromosome Aberrations</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0000768&amp;fLockTerm=Congenital+Abnormalities">Congenital Abnormalities</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0010210&amp;fLockTerm=Counseling">Counseling</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0010405&amp;fLockTerm=Cryopreservation">Cryopreservation</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0010674&amp;fLockTerm=Cystic+Fibrosis">Cystic Fibrosis</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0015915&amp;fLockTerm=Fertilization+in+Vitro">Fertilization in Vitro</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0017382&amp;fLockTerm=Genetic+Counseling">Genetic Counseling</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0679560&amp;fLockTerm=Genetic+Testing">Genetic Testing</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0021359&amp;fLockTerm=Infertility">Infertility</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0021361&amp;fLockTerm=Infertility%2c+Female">Infertility, Female</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0021364&amp;fLockTerm=Infertility%2c+Male">Infertility, Male</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0022526&amp;fLockTerm=Karyotyping">Karyotyping</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0032972&amp;fLockTerm=Pregnancy+Outcome">Pregnancy Outcome</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0086142&amp;fLockTerm=Preimplantation+Diagnosis">Preimplantation Diagnosis</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0033052&amp;fLockTerm=Prenatal+Care">Prenatal Care</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0949811&amp;fLockTerm=Reproductive+Techniques%2c+Assisted">Reproductive Techniques, Assisted</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C2717901&amp;fLockTerm=Single+Embryo+Transfer">Single Embryo Transfer</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0455164&amp;fLockTerm=Sperm+Injections%2c+Intracytoplasmic">Sperm Injections, Intracytoplasmic</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MSH_CUI=C0080265&amp;fLockTerm=Ultrasonography%2c+Prenatal">Ultrasonography, Prenatal</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0872104&amp;fLockTerm=Assisted+Reproductive+Technologies">Assisted Reproductive Technologies</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0008625&amp;fLockTerm=Chromosome+Aberrations">Chromosome Aberrations</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0000768&amp;fLockTerm=Congenital+Abnormality">Congenital Abnormality</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0010210&amp;fLockTerm=Counseling">Counseling</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0010674&amp;fLockTerm=Cystic+Fibrosis">Cystic Fibrosis</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0021361&amp;fLockTerm=Female+infertility">Female infertility</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0015915&amp;fLockTerm=Fertilization+in+Vitro">Fertilization in Vitro</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C1522577&amp;fLockTerm=follow-up">follow-up</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0017382&amp;fLockTerm=Genetic+Counseling">Genetic Counseling</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0679560&amp;fLockTerm=Genetic+screening+method">Genetic screening method</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0021359&amp;fLockTerm=Infertility">Infertility</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0497489&amp;fLockTerm=INFERTILITY%2fSUBFERTILITY+MALE">INFERTILITY/SUBFERTILITY MALE</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0022526&amp;fLockTerm=Karyotype+determination+procedure">Karyotype determination procedure</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0021364&amp;fLockTerm=Male+infertility">Male infertility</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712203141/https://www.guideline.gov/search?f_MTH_CUI=C0033052&amp;fLockTerm=Prenatal+care">Prenatal care</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0033052&amp;fLockTerm=Antenatal+care">Antenatal care</a>
 (424525001), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C3532201&amp;fLockTerm=Chromosome+microdeletion">Chromosome microdeletion</a>
 (471282000), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0000768&amp;fLockTerm=Congenital+malformation">Congenital malformation</a>
 (107656002), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0000768&amp;fLockTerm=Congenital+malformation">Congenital malformation</a>
 (21390004), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0000768&amp;fLockTerm=Congenital+malformation">Congenital malformation</a>
 (276654001), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0000768&amp;fLockTerm=Congenital+malformation">Congenital malformation</a>
 (276655000), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0000768&amp;fLockTerm=Congenital+malformation">Congenital malformation</a>
 (385297003), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010210&amp;fLockTerm=Counseling">Counseling</a>
 (129441002), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010210&amp;fLockTerm=Counseling">Counseling</a>
 (409063005), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010405&amp;fLockTerm=Cryopreservation">Cryopreservation</a>
 (88094004), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010674&amp;fLockTerm=Cystic+fibrosis">Cystic fibrosis</a>
 (190905008), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0200920&amp;fLockTerm=Cystic+fibrosis%2c+prenatal+detection">Cystic fibrosis, prenatal detection</a>
 (67799006), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0455164&amp;fLockTerm=Direct+injection+of+sperm+into+cytoplasm+of+the+oocyte">Direct injection of sperm into cytoplasm of the oocyte</a>
 (225244002), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0029975&amp;fLockTerm=Egg+donor">Egg donor</a>
 (430882007), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021361&amp;fLockTerm=Female+infertility">Female infertility</a>
 (6738008), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0412563&amp;fLockTerm=Fetal+anatomy+study">Fetal anatomy study</a>
 (271442007), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0017382&amp;fLockTerm=Genetic+counseling">Genetic counseling</a>
 (79841006), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0679560&amp;fLockTerm=Genetic+test">Genetic test</a>
 (405824009), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015915&amp;fLockTerm=In+vitro+fertilization">In vitro fertilization</a>
 (52637005), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021359&amp;fLockTerm=Infertile">Infertile</a>
 (15296000), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021359&amp;fLockTerm=Infertile">Infertile</a>
 (8619003), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0022526&amp;fLockTerm=Karyotype+determination">Karyotype determination</a>
 (312948004), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021364&amp;fLockTerm=Male+infertility">Male infertility</a>
 (2904007), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
 (289908002), <a href="/web/20180712203141/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0729353&amp;fLockTerm=Subfertility">Subfertility</a>
 (313279000)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712203141/https://www.guideline.gov/search?f_SPN_CUI=C0183135&amp;fLockTerm=IMAGER%2c+ULTRASONIC+OBSTETRIC-GYNECOLOGIC">IMAGER, ULTRASONIC OBSTETRIC-GYNECOLOGIC</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712203141/https://www.guideline.gov/search?f_UMD_CUI=C0183135&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic%2c+Obstetric%2fGynecologic">Scanning Systems, Ultrasonic, Obstetric/Gynecologic</a>
 (15-657)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/downloadcontent/ngc-10292?contentType=pdf" class="pdf">.PDF 91.5 kb</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/downloadcontent/ngc-10292?contentType=word" class="word">Word Document 285.3 kb</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/downloadcontent/ngc-10292?contentType=xml" class="xml">.XML 35.9 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712203141/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/47875/pregnancy-outcomes-after-assisted-human-reproduction" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712203141/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/47875/pregnancy-outcomes-after-assisted-human-reproduction" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712203141/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/47875/pregnancy-outcomes-after-assisted-human-reproduction&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712203141/mailto:/?Subject=AHRQ: Pregnancy outcomes after assisted human reproduction.&amp;body=https://www.guideline.gov/summaries/summary/47875/pregnancy-outcomes-after-assisted-human-reproduction" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Pregnancy outcomes after assisted human reproduction. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2014 Jan 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875">RefWorks</a></li>
                            <li><a href="/web/20180712203141/https://www.guideline.gov/summaries/citedownload/47875?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="47875" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The quality of evidence assessment (<strong>I-III</strong>) and classification of recommendations (<strong>A-E, L</strong>) are defined at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Outcomes Associated with Untreated Infertility</span></strong></p>
<p><em>Summary Statement</em></p>
<ol style="list-style-type: decimal;" start="1">
    <li>There is increasing evidence that infertility or subfertility is an independent risk factor for obstetrical complications and adverse perinatal outcomes, even without the addition of assisted human reproduction (AHR). (<strong>II-2</strong>) </li>
</ol>
<p><strong><span style="text-decoration: underline;">Outcomes Associated with Male Factor Infertility</span></strong></p>
<p><em>Recommendations</em></p>
<ol style="list-style-type: decimal;" start="1">
    <li>All men with severe oligozoospermia or azoospermia (sperm count &lt;5 million/hpf) should be offered genetic/clinical counselling, karyotype assessment for chromosomal abnormalities, and Y-chromosome microdeletion testing prior to in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). (<strong>II-2A</strong>) </li>
    <li>All men with unexplained obstructive azoospermia should be offered genetic/clinical counseling and genetic testing for cystic fibrosis prior to IVF with ICSI. (<strong>II-2A</strong>) </li>
</ol>
<p><strong><span style="text-decoration: underline;">Obstetrical, Perinatal, and Long-Term Outcomes Associated with Assisted Reproductive Technology</span></strong></p>
<p><strong>Multiple Pregnancy and Adverse Obstetrical and Perinatal Outcomes</strong></p>
<p><em>Recommendations</em></p>
<ol style="list-style-type: decimal;" start="3">
    <li>Multiple pregnancy is the most powerful predictive factor for adverse maternal, obstetrical, and perinatal outcomes. Couples should be thoroughly counselled about the significant risks of multiple pregnancies associated with all assisted human reproductive treatments. (<strong>II-2A</strong>) </li>
    <li>The benefits and cumulative pregnancy rates of elective single embryo transfer (eSET) support a policy of using this protocol in couples with good prognosis for success, and eSET should be strongly encouraged in this population. (<strong>II-2A</strong>) </li>
    <li>To reduce the incidence of multiple pregnancy, health care policies that support public funding for AHR, with regulations promoting best practice regarding eSET, should be strongly encouraged. (<strong>II-2A</strong>) </li>
</ol>
<p><strong>Singleton Pregnancies and Perinatal Outcome/Preterm Birth/Low Birth Weight</strong></p>
<p><em>Recommendations</em></p>
<ol style="list-style-type: decimal;" start="6">
    <li>Among singleton pregnancies, assisted reproductive technology (ART) is associated with increased risks of preterm birth and low birth weight infants, and ovulation induction (OI) is associated with an increased risk of low birth weight infants. Until sufficient research has clarified the independent roles of infertility and treatment for infertility, couples should be counselled about the risks associated with treatment. (<strong>II-2B</strong>) There is a role for closer obstetric surveillance for women who conceive with AHR. (<strong>III-L</strong>) </li>
    <li>There is growing evidence that pregnancy outcomes are better for cryopreserved embryos fertilized in vitro than for fresh embryo transfers. This finding supports a policy of eSET for women with a good prognosis (with subsequent use of cryopreserved embryos as necessary), and may reassure women who are considering IVF. (<strong>II-2A</strong>) </li>
    <li>Women and couples considering AHR and concerned about perinatal outcomes in singleton pregnancies should be advised that (1) ICSI does not appear to confer increased adverse perinatal or maternal risk over standard IVF, and (2) the use of donor oocytes increases successful pregnancy rates in selected women, but even when accounting for maternal age, can increase the risk of low birth weight and preeclampsia. (<strong>II-2B</strong>) </li>
</ol>
<p><strong><span style="text-decoration: underline;">Fetal Structural, Chromosomal, and Imprinting Abnormalities Associated with Assisted Human Reproduction</span></strong></p>
<p><strong>Structural Abnormalities (Malformations, Deformations, and Disruptions)</strong></p>
<p><em>Recommendations</em></p>
<ol style="list-style-type: decimal;" start="9">
    <li>Any ART procedure should be prefaced by a discussion of fetal outcomes and the slight increase in the risk of congenital structural abnormalities, with emphasis on known confounding factors such as infertility and body mass index. (<strong>II-2B</strong>) </li>
    <li>In pregnancies achieved by ART, routine anatomic ultrasound for congenital structural abnormalities is recommended between 18 and 22 weeks. (<strong>II-2A</strong>) </li>
</ol>
<p><strong>Chromosomal Disorders</strong></p>
<p><em>Recommendation</em></p>
<ol style="list-style-type: decimal;" start="11">
    <li>Pregnancies conceived by ISCI may be at increased risk of chromosomal aberrations, including sex chromosome abnormalities. Diagnostic testing should be offered after appropriate counselling. (<strong>II-2A</strong>) </li>
</ol>
<p><strong>Imprinting Disorders</strong></p>
<p><em>Summary Statement</em></p>
<ol style="list-style-type: decimal;" start="2">
    <li>The relative risk for an imprinting phenotype such as Silver-Russell syndrome, Beckwith-Wiedemann syndrome, or Angelman syndrome is increased in the assisted reproduction population, but the actual risk for one of these phenotypes to occur in an assisted pregnancy is estimated to be low, at less than 1 in 5000. The exact biological etiology for this imprinting risk increase is likely heterogeneous and requires more research. (<strong>II-2</strong>) </li>
</ol>
<p><em>Recommendation</em></p>
<ol style="list-style-type: decimal;" start="12">
    <li>The possible increased risk for late onset cancer due to gene dysregulation for tumour suppression requires more long-term follow-up before the true risk can be determined. (<strong>III-A</strong>) </li>
</ol>
<p><strong>Preimplantation Genetic Screening</strong></p>
<p><em>Recommendations</em></p>
<ol style="list-style-type: decimal;" start="13">
    <li>The clinical application of preimplantation genetic testing in fertile couples must balance the benefits of avoiding disease transmission with the medical risks and financial burden of IVF. (<strong>III-B</strong>) </li>
    <li>Preimplantation screening for aneuploidy is associated with inconsistent findings for improving pregnancy outcomes. Any discussion of preimplantation genetic screening with patients should clarify that there is no adequate information on the long-term effect of embryo single cell biopsy. (<strong>I-C</strong>) </li>
</ol>
<p><span style="text-decoration: underline;"><strong>Definitions</strong></span>:</p>
<p><strong>Quality of Evidence Assessment*</strong></p>
<p><strong>I</strong>: Evidence obtained from at least one properly randomized controlled trial</p>
<p><strong>II-1</strong>: Evidence from well-designed controlled trials without randomization</p>
<p><strong>II-2</strong>: Evidence from well-designed cohort (prospective or retrospective) or case-control studies, preferably from more than one centre or research group</p>
<p><strong>II-3</strong>: Evidence obtained from comparisons between times or places with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of treatment with penicillin in the 1940s) could also be included in this category</p>
<p><strong>III</strong>: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees</p>
<p class="Note">*Adapted from the Evaluation of Evidence criteria described in the Canadian Task Force on Preventive Health Care.</p>
<p><strong>Classification of Recommendations<sup>&dagger;</sup></strong></p>
<p><strong>A.</strong> There is good evidence to recommend the clinical preventive action</p>
<p><strong>B.</strong> There is fair evidence to recommend the clinical preventive action</p>
<p><strong>C.</strong> The existing evidence is conflicting and does not allow to make a recommendation for or against use of the clinical preventive action; however, other factors may influence decision-making</p>
<p><strong>D.</strong> There is fair evidence to recommend against the clinical preventive action</p>
<p><strong>E.</strong> There is good evidence to recommend against the clinical preventive action</p>
<p><strong>L.</strong> There is insufficient evidence (in quantity or quality) to make a recommendation; however, other factors may influence decision-making</p>
<p class="Note">&dagger;Adapted from the Classification of Recommendations criteria described in the Canadian Task Force on Preventive Health Care.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Assisted human reproduction (AHR) pregnancies</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Counseling</p>
                    <p>Management</p>
                    <p>Risk Assessment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Medical Genetics</p>
                    <p>Obstetrics and Gynecology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Nurses</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>To review the effect of assisted human reproduction (AHR) on perinatal outcomes </li>
    <li>To identify areas requiring further research with regard to birth outcomes and AHR </li>
    <li>To provide guidelines to optimize obstetrical management and counselling of prospective Canadian parents </li>
</ul></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Infertile and subfertile women and men</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;" start="1">
    <li>Consideration of infertility or subfertility as an independent risk factor for obstetrical complications and adverse perinatal outcomes </li>
    <li>Male factor infertility
    <ul style="list-style-type: disc;">
        <li>Genetic/clinical counselling </li>
        <li>Karyotype assessment for chromosomal abnormalities </li>
        <li>Y-chromosome microdeletion testing </li>
        <li>Genetic testing for cystic fibrosis </li>
    </ul>
    </li>
    <li>Assisted reproductive technology (ART)
    <ul style="list-style-type: disc;">
        <li>Counselling on risks of ART (multiple pregnancies, preterm birth, low birth weight) </li>
        <li>Benefits of elective single embryo transfer (eSET) </li>
        <li>Consideration of cryopreserved embryos fertilized in vitro vs. fresh embryo transfers </li>
        <li>Advisement concerning intracytoplasmic sperm injection (ICSI) and use of donor oocytes </li>
    </ul>
    </li>
    <li>Assisted human reproduction (AHR) associated fetal structural, chromosomal and imprinting abnormalities
    <ul style="list-style-type: disc;">
        <li>Patient counseling on risks of congenital structural abnormalities </li>
        <li>Routine anatomic ultrasound </li>
        <li>Risk of chromosomal aberrations and imprinting disorders </li>
        <li>Long-term follow-up for possible risk of late onset cancer </li>
    </ul>
    </li>
    <li>Preimplantation genetic testing </li>
    <li>Close obstetric surveillance for AHR pregnancies </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Obstetrical complications </li>
    <li>Adverse perinatal outcomes </li>
    <li>Multiple gestations </li>
    <li>Structural congenital abnormalities </li>
    <li>Chromosomal abnormalities </li>
    <li>Imprinting disorders </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                    <p>Searches of Unpublished Data</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>Published literature was retrieved through searches of Ovid MEDLINE and the Cochrane Library for English-language articles related to assisted reproduction and perinatal outcomes published from January 2005 to December 2012 (overlapping with the previous Society of Obstetricians and Gynaecologists of Canada guideline) using appropriate controlled vocabulary and key words (assisted reproduction, assisted reproductive technology, ovulation induction, intracytoplasmic sperm injection, embryo transfer, and in vitro fertilization). Results were not restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies; studies of all designs published in English from January 2005 to December 2012 were reviewed, and additional publications were identified from the bibliographies of these articles. Well-conducted randomized controlled trials were considered evidence of the highest quality, followed by cohort studies. Searches were updated on a regular basis and incorporated in the guideline to August 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Quality of Evidence Assessment*</strong></p>
<p><strong>I</strong>: Evidence obtained from at least one properly randomized controlled trial</p>
<p><strong>II-1</strong>: Evidence from well-designed controlled trials without randomization</p>
<p><strong>II-2</strong>: Evidence from well-designed cohort (prospective or retrospective) or case-control studies, preferably from more than one centre or research group</p>
<p><strong>II-3</strong>: Evidence obtained from comparisons between times or places with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of treatment with penicillin in the 1940s) could also be included in this category</p>
<p><strong>III</strong>: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees</p>
<p class="Note">*Adapted from the Evaluation of Evidence criteria described in the Canadian Task Force on Preventive Health Care.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (see the "Rating Scheme for the Strength of the Evidence" field).</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Classification of Recommendations&dagger;</strong></p>
<p><strong>A</strong>. There is good evidence to recommend the clinical preventive action</p>
<p><strong>B</strong>. There is fair evidence to recommend the clinical preventive action</p>
<p><strong>C</strong>. The existing evidence is conflicting and does not allow to make a recommendation for or against use of the clinical preventive action; however, other factors may influence decision-making</p>
<p><strong>D</strong>. There is fair evidence to recommend against the clinical preventive action</p>
<p><strong>E</strong>. There is good evidence to recommend against the clinical preventive action</p>
<p><strong>L</strong>. There is insufficient evidence (in quantity or quality) to make a recommendation; however, other factors may influence decision-making</p>
<p class="Note">&dagger;Adapted from the Classification of Recommendations criteria described in the Canadian Task Force on Preventive Health Care.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>The potential impact of a policy of elective single embryo transfer (eSET) in appropriately selected women on perinatal and maternal outcomes is significant, and such a policy could result in substantial cost savings. One modelling study examined the cost utility of this policy, and a multi-centre cohort examining the long-term effects and cost implications of the Dutch policy of eSET is ongoing.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>This clinical practice guideline has been prepared by the Genetics Committee, reviewed by the Reproductive Endocrinology and Infertility Committee and the Family Physicians Advisory Committee, and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Appropriate obstetrical management and counseling of prospective parents regarding assisted human reproduction (AHR) procedures </li>
    <li>Clinicians who are better informed about the adverse effects that have been documented in association with AHR </li>
</ul></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>This document reflects emerging clinical and scientific advances on the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate amendments to these opinions. They should be well documented if modified at the local level. None of these contents may be reproduced in any form without prior written permission of the Society of Obstetricians and Gynaecologists of Canada (SOGC).</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Foreign Language Translations</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Staying Healthy</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Society of Obstetricians and Gynaecologists of Canada, Okun N, Sierra S. Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can. 2014 Jan;36(1):64-83. [176 references] <a href="https://web.archive.org/web/20180712203141/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=24444289" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712203141im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2006 Mar (revised 2014 Jan)</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>Society of Obstetricians and Gynaecologists of Canada (SOGC)</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Genetics Committee</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Principal Authors</em>: Nanette Okun, MD, Toronto ON; Sony Sierra, MD, Toronto ON</p>
<p><em>Genetics Committee</em>: R. Douglas Wilson (<em>Chair</em>), MD, Calgary AB; Francois Audibert, MD, Montreal QC; Jo-Ann Brock, MD, PhD, Halifax NS; Carla Campagnolo, MSc, CCGC, London ON; June Carroll, MD, Toronto ON; Lola Cartier, MSc, CCGC, Montreal QC; David Chitayat, MD, Toronto ON; Alain Gagnon, MD, Vancouver BC; Jo-Ann Johnson, MD, Calgary AB; Sylvie Langlois, MD, Vancouver BC; Lynn Murphy-Kaulbeck, MD, Moncton NB; W. Kim MacDonald, MD, Halifax NS; Nanette Okun, MD, Toronto ON; Melanie Pastuck, RN, Cochrane AB</p>
<p><em>Special Contributors</em>: Lih Yeen Tan, MD, Toronto ON; Valda Poplak, Toronto ON; Helen Robson, MA, Toronto</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Disclosure statements have been received from all contributors.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Allen VM, Wilson RD, Cheung A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC); Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC). Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006 Mar;28(3):220-50. [117 references]</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Electronic copies: Available from the <a href="/web/20180712203141/https://www.guideline.gov/Home/Disclaimer?id=47875&amp;contentType=summary&amp;redirect=http%3a%2f%2fsogc.org%2fguidelines%2fpregnancy-outcomes-assisted-human-reproduction%2f" title="Society of Obstetricians and Gynaecologists of Canada (SOGC) Web site">Society of Obstetricians and Gynaecologists of Canada (SOGC) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712203141im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. Also available in French from the <a href="/web/20180712203141/https://www.guideline.gov/Home/Disclaimer?id=47875&amp;contentType=summary&amp;redirect=http%3a%2f%2fsogc.org%2ffr%2fguidelines%2fpregnancy-outcomes-assisted-human-reproduction%2f" title="Society of Obstetricians and Gynaecologists of Canada Web site">SOGC Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712203141im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p>
<p>Print copies: Available from the Society of Obstetricians and Gynaecologists of Canada, La soci&eacute;t&eacute; des obst&eacute;triciens et gyn&eacute;cologues du Canada (SOGC) 780 promenade Echo Drive Ottawa, ON K1S 5R7 (Canada); Phone: 1-800-561-2416.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on May 7, 2014. The information was verified by the guideline developer on June 4, 2014.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712203141/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712203141/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712203141/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203141/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203141/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203141/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203141/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203141/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712203141/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712203141/https://www.guideline.gov/disclaimer?id=47875&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712203141/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712203141/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712203141/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712203141/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712203141/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712203141/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712203141/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712203141/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712203141/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712203141/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712203141/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712203141/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712203141/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712203141/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712203141im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712203141/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712203141/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712203141js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712203141js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:31:41 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:19:30 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 125.587 (3)
  esindex: 0.013
  captures_list: 147.548
  CDXLines.iter: 15.573 (3)
  PetaboxLoader3.datanode: 74.572 (4)
  exclusion.robots: 0.257
  exclusion.robots.policy: 0.238
  RedisCDXSource: 1.944
  PetaboxLoader3.resolve: 43.595
  load_resource: 25.614
-->